Trial NCT03324243

View at ClinicalTrials.gov 
Org. Study IDs: ARO-014

Last trial update was posted on 2019-01-10

MeSH Interventions

Crenolanib Cytarabine Fludarabine

MeSH Conditions

Leukemia, Myeloid, Acute

Other Conditions

Relapsed/Refractory FLT3-mutated AML

Stopping Reasons

Withdrawn: Study halted prior to enrollment of first participant

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID